Wilson Sonsini Goodrich & Rosati advised SR One Capital Management on the deal. ADARx Pharmaceuticals, Inc., a biotechnology company developing RNA targeting therapeutics, announced the completion...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Logos Capital on the deal while Sidley represented Attralus, Inc. Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised SimpliPhi Power on the deal. Briggs & Stratton, a recognized global leader in providing power to get work done, has...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Earthshot Ventures on the deal. Earthshot Ventures, a new venture capital fund launched to support entrepreneurs tackling climate change, announced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised InBrace on the deal while Crowell & Moring represented Marshall Wace. InBrace, the orthodontic company behind the novel Smartwire™ category...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Helens International Holdings Company Limited on the deal, while Davis Polk advised the underwriter. Helens International Holdings Company Limited (Helens)...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised SR One on the deal. ARS Pharmaceuticals, Inc., a pharmaceutical company dedicated to empowering at-risk patients and caregivers to better...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Humane, Inc. on the deal. Humane, Inc. announced it has raised $100 million in its Series B round, which was...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Kevala on the deal. Kevala Inc., a nationwide leader in energy data and analytics, has raised $21 million in a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Fenwick & West advised DiCE Molecules on the deal. DiCE Molecules, a biopharmaceutical company leveraging its proprietary DNA-encoded library platform...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ginger on the deal, while Latham & Watkins represented Headspace. Ginger, a leading provider of on-demand mental healthcare, and Headspace, a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Vida Ventures on the deal while Goodwin Procter represented Vigil Neuroscience. Vigil Neuroscience, a biotechnology company harnessing the power of...
You must be a Standard 1 Year member to access this content.
